Our findings suggest an enhanced A2AR activity in the NTS of epileptic mice - while LFP alteration can result from a local modulation by A2AR and/or potentially by a long-distance network effect triggered by A2AR in different brain regions - and provide experimental evidence supporting A2AR as a therapeutic target for SUDEP prevention. This evidence concerns the gene ADORA2A and Sudden unexpected death in epilepsy.